Press Release Feb 17, 2026 Lumanity Becomes First Life Sciences Value Demonstration Partner to Achieve ISO 42001 Certification, Setting a New Standard for Responsible AI in Life Sciences
Press Release Feb 17, 2026 Lumanity Becomes First Life Sciences Value Demonstration Partner to Achieve ISO 42001 Certification, Setting a New Standard for Responsible AI in Life Sciences
View Feb 27, 2026 Rare Disease Day 2026: Moving Forward with FDA Innovation and Patient-Centered Progress Take a look
On-Demand Webinar Feb 26, 2026 Navigating Value Creation in Cell & Gene Therapy: Strategy, Access, and Adoption
On-Demand Webinar Feb 24, 2026 Have Cancer Vaccines Come of Age (or Do They Remain the Unruly Adolescent)?
On-Demand Webinar Dec 9, 2025 Building Value Early: Differentiation and Patient-Centric Strategy in the Pipeline
On-Demand Webinar Nov 19, 2025 Next Gen Biologics and the Evolution of Immunotherapy: What Does the Future Hold for IO?
On-Demand Webinar Oct 14, 2025 Embedding Patient-Centricity Across Biopharma: From Asset to Enterprise Transformation
On-Demand Webinar Oct 2, 2025 Navigating The Storm: Key challenges for pharmaceutical manufacturers in an evolving US market
On-Demand Webinar Sep 15, 2025 Accelerating Clinical Trials: Winning the High-Stakes Race Against Time
On-Demand Webinar Sep 11, 2025 Keeping Hope Alive: Learnings on How Pre-POC Oncology Biotech Can Successfully Navigate Current Challenging Times
On-Demand Webinar Jun 26, 2025 Beyond Hashtags: Using Real Health Conversations to Deliver Meaningful Insights and Authentic Engagement
On-Demand Webinar May 13, 2025 Immunotherapy’s Wild Ride: From Neglect to Stardom to Pariah – and Now Maybe Phoenix
On-Demand Webinar Nov 20, 2024 Upgrading ADCs to the Next Level: What Does the Future of Antibody Drug Conjugates Look Like?
